long intergenic non-protein coding RNA 2073Genealiases: []
Q-omics provides the consensus-scored LINC02073 profile across patient tissues and cancer cell-line models. LINC02073 expression is associated with patient survival in 24 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, LINC02073 is differentially expressed in 10, with the highest sampling consensus in HNSC. Additionally, LINC02073 RNA expression shows 10,323 significant gene co-expression associations, with the highest sampling consensus in READ. Together, these results highlight KIRC, HNSC, and READ as cancer lineages where LINC02073 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02073 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02073 survival associations across molecular data types. LINC02073 RNA expression shows survival associations in the most cancer types (24). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02073 RNA expression–survival associations across cancer types. High LINC02073 expression shows unfavorable associations in STAD and LGG, but favorable associations in KIRC, CESC, OV and SKCM. The KIRC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for LINC02073 RNA expression.
This table summarizes LINC02073 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02073. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02073 shows higher tumor expression in HNSC, KIRC, BRCA, LUAD, COAD and KIRP. The HNSC box plot shows higher LINC02073 RNA expression in tumor versus normal tissue (log2 FC = +0.275, t-test p < 0.001).
This table shows molecular features associated with LINC02073 in patient tissues and cancer cell lines. In patient samples, LINC02073 shows the broadest associations at the RNA and protein expression levels, with READ recurring as the lineage with the largest associated feature set.
